Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) Reports Record Sales and Net Income
Date:11/21/2008

XI'AN, China, Nov. 21 /PRNewswire-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, is pleased to announce record sales and earnings for the three and nine month periods ended September 30, 2008.

"We are pleased to announce that in the third quarter of 2008, Huifeng has managed to record both record sales and net income. Product revenue was over $3.5 million, representing an increase of 82% year over year. Net income in the quarter was $768 thousand, which equates to 4 cents per share and is an increase of 130% over the prior year's earnings."

According to Mr. Wang, the nine month earnings and sales figures also represent record levels for HFGB. Mr. Wang further stated that Net Income through 9 months was strong at eight cents per share, despite being negatively impacted by expenses related to the company's recent financing activity.

"Huifeng, despite the uncertain global economic environment, continues to execute to our strategic growth plan. The third quarter was a significant quarter for the Company as we not only reported record levels of income, but we closed on our first acquisition," said Mr. Wang.

Gross margins for Huifeng improved to 38%, up from last year's 28%. Strength in the Company's main product lines of Rutin, Diosmin, and L-Rhamnose continue to drive sales.

"We are very excited about the results of the third quarter and hope to build upon them going forward. COS approval is expected in the near future, allowing us to begin sales of Diosmin to our strategic partner Safic-Alcan of France. We are entering a very exciting phase of Huifeng's corporate development and are looking forward to demonstrating the strength of our quality platform and products throughout the remainder of FY
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Huifeng Bio-Pharmaceutical (HFGB) Announces Participation in the 59th PHARMCHINA Expo
2. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
3. China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Quarter 2008
4. Nutraceutical Reports 2008 Fiscal Year End Results
5. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through Third Quarter, 2008
6. Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter
7. Escalon(R) Reports First Quarter Fiscal 2009 Results
8. PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer
9. PA Health Department Reports Southeast Regions First Lab-Confirmed Influenza Case of the Season
10. CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions
11. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Until now, little was scientifically known about the human ... caring for people who are suffering in a way ... by researchers at the Center for Investigating Healthy Minds ... shows that adults can be trained to be more ... Psychological Science , is the first to investigate ...
(Date:5/23/2013)... New techniques in imaging of brain activity developed ... Neurological Institute, and his colleagues lead to improved ... combination of electroencephalogram (EEG) and functional magnetic resonance ... the areas generating epileptic seizures, giving neurosurgeons a ... if appropriate. These results were presented at ...
(Date:5/23/2013)... WEDNESDAY, May 22 (HealthDay News) -- Physicians weighing the benefits ... have more information to help with the decision. A new ... scans pick up significantly more lung tumors than chest X-rays ... at high risk for lung cancer, the deadliest form of ... the potential harm of radiation exposure when ordering screening. ...
(Date:5/23/2013)... 2013 Located at 22343 La Palma Ave. ... Linda held its Grand Opening Family Fun Charity event on ... multiple sclerosis and physical fitness. Sponsored by many different vendors ... the fun filled Grand Opening featured mini boot camp sessions ... community what the Yorba Linda fitness center has ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... to announce the launch of Current Digital, a ... web development and digital marketing needs. Companies now ... a strategic business necessity. This can often leave ... creative strategy on preselected software platforms that they ...
Breaking Medicine News(10 mins):Health News:Study shows people can be trained to be more compassionate 2Health News:Study shows people can be trained to be more compassionate 3Health News:Study shows people can be trained to be more compassionate 4Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 2Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 3
... Bradford, from Oswestry, a patient with breast cancer in England ... are given free drug treatment// at a hospital. Local health ... the Shropshire Primary Care Trust. The patients in Shropshire have ... protest at the hospital on Monday. ,North Shropshire ...
... London, the cause of autism may now be explained due t ... not interacting well with other people. Weak links between brain areas ... situations as well as other people. ,The study ... an Autism Spectrum Disorder (ASD) while the other 16 did not. ...
... NHS trust failed to adequately supervise two doctors. Amit ... Hospital. It led to the death of the patient ... surgery. He suffered toxic shock syndrome. The hospital ... house officers. ,At a sentencing hearing at ...
... According to a new study of women with early stage, ... disease have been identified that may influence how patients are ... patients from 1988 to 2002 was reviewed by Cancer Research ... are risk factors for invasive disease and the pattern of ...
... Office (NHSO) has found that women aged above 35 are ... should annually undergo a Pap smear test for early detection ... is the most common type of cancer among women. ... scheme, has provided Pap smear services to 1.5 million women ...
... heart's largest artery, the aorta. Studies were going on to ... Johns Hopkins University// have successfully come up with the treatment. ... in recent studies for treating the genetic disorder. The ... appears to prevent the weakening of the heart's largest artery, ...
Cached Medicine News:Health News:Cancer Patients Protest For Free Drug Treatment 2Health News:Lack Of Communication Between Brain Areas Can Cause Autism 2
(Date:5/23/2013)... , Engeland, May 23, 2013 ... mannen met lagere urinewegsymptomen geassocieerd met BPH ... Europese dochteronderneming van Astellas Pharma Inc, gebaseerd in ... 4503), kondigde vandaag aan dat het Nederlandse College ter ... VESOMNI in Nederland. De handelsvergunning verleend voor ...
(Date:5/23/2013)... Mai 2013 Ranbaxy Laboratories ... von Daiichi Sankyo Co., Ltd. (im ... Mai die Maßnahmen bekannt, die Ranbaxy ... um sich der Angelegenheiten der vorhergehenden ... ). Daiichi Sankyo unterstützt ...
(Date:5/22/2013)... LOVELAND, Colo. , May 22, 2013  Heska Corporation ... veterinary diagnostic and specialty products, announced today that the Company ... on Wednesday, May 29, 2013 at the Le Parker Meridian ... New York City . The presentation is scheduled to ... About Heska Heska Corporation (NASDAQ: ...
Breaking Medicine Technology:Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... March 3, 2011 Tom McLeer, GM of Spine and ... in Marquette, MI, announces the appointment of Jim St. John ... Jim has 25 years of experience in the spine industry; ... 5 languages.  Jim last worked for Benvenue Medical where he ...
... March 3, 2011 InstaCare Corp. (OTC Bulletin Board: ... drugs, home testing products for the chronically ill, a ... and a leading developer of revolutionary patent pending cell ... announced that it has migrated its recently patent pending ...
Cached Medicine Technology:Pioneer® Surgical Announces New International Sales V.P. 2InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 2InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 3
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
... Designed for precise punching of the ... designed for use with disposable trephine ... aids in centration of the donor ... block is held centrally under the ...
Broad Tip and Ultra-Micro Needle Tip, sterile, 10 per Box, 10 Boxes per Case...
Medicine Products: